Researchers at the University of Massachusetts Amherst have discovered a small strand of microRNA, or miRNA, known as let-7, that appears to play a crucial role in the ability of T-cells to recognize and remember tumor cells, a fundamental mechanism in the effectiveness of vaccines and a potentially pivotal point in advancing cancer therapies.
The findings of this research were published in Nature Communications and hint at promising advancements in immunotherapies aimed at combating cancer.
T-cells, a type of white blood cell, specialize in combating pathogens like the common cold and altered self-cells like tumor cells. Typically, T-cells are “naïve,” or inactive.
However, upon recognition of foreign antigens, they become active, transforming into killer T-cells that attack the identified pathogen, ranging from viruses to cancer cells.
After their battle, some T-cells transform into memory cells, forming a ‘memory pool’ that remembers specific antigens and remains vigilant against future invasions.
The research led by Leonid Pobezinsky, associate professor of veterinary and animal sciences at UMass Amherst, discovered that the microRNA let-7, conserved evolutionarily since early animal life, is highly expressed in these memory cells.
The study revealed that the amount of let-7 in a cell is inversely proportional to the chance of the cell being tricked by cancerous tumor cells and directly proportional to its chances of transforming into a memory cell.
Cancerous cells often deceive killer T-cells, disabling them before they can attack and create a memory pool, which allows the cancer to metastasize unchecked.
However, if a memory cell is not deceived by the cancer, it can not only fight the cancer but also remember the cancerous cell’s characteristics.
Understanding the role of let-7 could be crucial in developing the next generation of cancer-fighting immunotherapies by providing insights into enhancing the memories and capabilities of our immune systems.
This knowledge is particularly promising as memory cells can live for extended periods, some potentially up to 70 years, and possess stem-cell-like features.
Memory cells with high levels of let-7 are less likely to be tricked by tumor cells, meaning they can effectively fight and remember cancerous cells, preventing further development and spread of the cancer.
This research provides fundamental insights and opens up promising avenues for exploring how let-7 is regulated during treatment to bolster the immune system’s memory and capabilities.
This innovative research reveals the significant role of microRNA let-7 in governing the memory formation of T-cells, offering new insights and strategies for developing advanced cancer immunotherapies.
The ability of let-7 to enhance the cellular memory against tumor cells provides a promising pathway for creating more effective treatments, harnessing our body’s natural defenses against cancer, and potentially other diseases.
Further studies on the regulation of let-7 during treatment are warranted to realize the translational impact of these findings in enhancing immunotherapies.
If you care about cancer, please read studies about how to reduce pancreatic cancer spread by nearly 90%, and green tea could help reduce death risk in type 2 diabetes
For more information about nutrition, please see recent studies that blackcurrants can reduce blood sugar after meal and results showing how drinking milk affects risks of heart disease and cancer.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
